Uchiyama, Kiyotaka
Mochizuki, Toshio
Shimada, Yosuke
Nishio, Saori
Kataoka, Hiroshi
Mitobe, Michihiro
Tsuchiya, Ken
Hanaoka, Kazushige
Ubara, Yoshifumi
Suwabe, Tatsuya
Sekine, Akinari
Nutahara, Kikuo
Tsuruya, Kazuhiko
Ishimura, Eiji
Nakatani, Shinya
Sofue, Tadashi
Tanaka, Satoshi
Narita, Ichiei
Maruyama, Shoichi
Horie, Shigeo
Muto, Satoru http://orcid.org/0000-0002-5400-5195
Funding for this research was provided by:
Ministry of Health, Labour and Welfare
Article History
Received: 9 February 2021
Accepted: 22 April 2021
First Online: 29 April 2021
Declarations
:
: Toshio Mochizuki received travel fees and honoraria for lectures from Otsuka Pharmaceutical Co. Toshio Mochizuki and Hiroshi Kataoka belong to an endowed department sponsored by Otsuka Pharmaceutical Co, Chugai Pharmaceutical Co, Kyowa Hakko Kirin Co, and JMS Co. Satoru Muto received travel fees and honoraria for lectures from Otsuka Pharmaceutical Co., Ltd. Shigeo Horie and Satoru Muto belong to an endowed department sponsored by Otsuka Pharmaceutical Co., Ltd., JENESIS Co., Ltd., Nippon Shinyaku Co., Ltd., Shokubunka Co., Ltd., and Rohto Pharmaceutical Co., Ltd..
: The study was conducted in accordance with the guidelines written in the Declaration of Helsinki. Ethics committees from each of the 14 institutions approved the study, and the Japanese Society of Nephrology approved the study (No. 6).
: Written informed consent was obtained from all individual participants included in the study.